ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
1.585
+0.035 (2.26%)
Jun 10, 2026, 10:36 AM EDT - Market open
ALX Oncology Holdings Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
43
Market Cap
213.28M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cellectis | 75.11M |
| Arcturus Therapeutics Holdings | 54.71M |
| Q32 Bio | 53.74M |
| Atrium Therapeutics | 36.68M |
| Voyager Therapeutics | 36.49M |
| Keros Therapeutics | 33.18M |
| LENZ Therapeutics | 20.99M |
| Whitehawk Therapeutics | 7.15M |
ALXO News
- 6 days ago - ALX Oncology Holdings Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 9 days ago - ALX Oncology to Present at the 2026 Jefferies Global Healthcare Conference in New York - GlobeNewsWire
- 4 weeks ago - ALX Oncology Holdings Earnings Call Transcript: Q1 2026 - Transcripts
- 4 weeks ago - ALX Oncology Holdings Earnings release: Q1 2026 - Filings
- 4 weeks ago - ALX Oncology Holdings Slides: Q1 2026 - Filings
- 4 weeks ago - ALX Oncology Holdings Quarterly report: Q1 2026 - Filings
- 4 weeks ago - ALX Oncology Reports First Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 weeks ago - ALX Oncology evorpacept combination data presented at ESMO congress - TheFly